Neuvotion Announces Commercialization of Brain-Computer Interface and Brain-Body Interface Technologies – Related Clinical Study Published in Nature Medicine
Neuvotion, Inc. is an early-stage medical device company developing an AI-guided neuromodulation platform to accelerate recovery after neurological events such as stroke and spinal cord injury. Its Brain-Body Interface (BBI) portfolio integrates wearable high-resolution muscle stimulation, spinal neuromodulation, and minimally invasive brain-computer interface (BCI) technologies to restore movement and sensation. By combining AI, intention-driven neurostimulation, and BCI technology, Neuvotion is translating newly published, peer-reviewed findings in Nature Medicine into commercially available solutions designed to help millions of people living with movement and sensory impairments regain function, independence, and quality of life.
